Posters remain on display throughout the meeting
Posters remain on display throughout the meeting
A comparison of antenatal characteristics of women with gestational diabetes according to ethnic background (#251)
1:30 PM
Overall diet quality score and type 2 diabetes (#252)
1:30 PM
ARFS items and type 2 diabetes in Australian women (#253)
1:30 PM
Are clinical trial participants different from the general diabetes population? Does it matter? (#254)
1:30 PM
Sexual dysfunction in adults with diabetes: Results from Diabetes MILES-Australia (#255)
1:30 PM
The needs, concerns, and characteristics of young Australian adults with type 2 diabetes (#256)
1:30 PM
Emotional well-being and social and economic disadvantage in severely obese people with type 2 diabetes: Results from Diabetes MILES – Australia (#257)
1:30 PM
The effects of commencing insulin pump therapy on glycaemic parameters in adult patients with type 1 diabetes – a CGMS study (#258)
1:30 PM
Liraglutide achieves HbA1c targets more often than sitagliptin or exenatide when added to metformin in patients with type 2 diabetes and a baseline HbA1c <8.0% (#259)
1:30 PM
Lower Rates in Overall and Nocturnal Hypoglycemia of Insulin Degludec vs. Insulin Glargine with Treatment Intensification in T2DM in Moderately Good Control (A1c 7.5–8.5%) at Baseline: A Meta-Analysis (#260)
1:30 PM
Clinical Experience with Exenatide: Case series of patients switched from insulin therapy to exenatide. (#261)
1:30 PM
Longitudinal Changes in Serum Lipid Profiles and Their Management in Representative Australian Patients with Type 2 Diabetes: The Fremantle Diabetes Study (#262)
1:30 PM
Frequency of hand and shoulder symptoms in T1diabetes (#263)
1:30 PM
The GLP-1 Receptor Agonist Liraglutide Attenuates Atherosclerotic Lesion Development and Potentially Enhances Plaque Stability in an ApoE-/- Mouse Model (#264)
1:30 PM
Does Diabetes Affect The Outcomes of Acute Pancreatitis? (#265)
1:30 PM
Fusion pore dynamics of insulin granules in intact islets of db/db mice (#266)
1:30 PM
Glycemic Control In Adolescents (#267)
1:30 PM
Glucose metabolism following stroke in people without diabetes (#268)
1:30 PM
Review of Patients with Diabetic Ketoacidosis Admitted to General Physician Care in a Tertiary Hospital (#269)
1:30 PM
Type 2 diabetes mellitus in the Southern Fleurieu area: progression from diagnosis to commencement of insulin therapy (#270)
1:30 PM
Economic Benefit of Combining Vildagliptin with Insulin (#271)
1:30 PM
A case-report of diabetic myonecrosis in an Indigenous male from the Torres Strait Islands (#272)
1:30 PM
An audit of psychological well-being in adults with type 1 diabetes attending tertiary diabetes clinics in Melbourne (#273)
1:30 PM
Prevalence of self-reported severe hypoglycaemia in adults with type 1 diabetes attending tertiary diabetes clinics in Melbourne (#274)
1:30 PM
How achievable is target HbA1c in insulin-treated type 2 diabetes (T2DM)? A multicentre study of 2025 patients from 8 specialist endocrine practices, including relationship of control to treatment centre and pattern of insulin administration (#275)
1:30 PM
Subjective wellbeing among adults with diabetes: Results from Diabetes MILES – Australia (#276)
1:30 PM
Haemoglobin age levels in type 1 diabetes patients are increased and correlate with vascular inflammation (#277)
1:30 PM
Plasma disappearance of inulin as a marker of glomerular filtration rate in type 2 diabetes (#278)
1:30 PM
Dietary AGE restriction for the attenuation of insulin resistance, oxidative stress and endothelial dysfunction. A systematic review. (#279)
1:30 PM
Diabetes care provision: Barriers, enablers and service needs of young adults with type 1 diabetes (#280)
1:30 PM
Risk factors for amputation in diabetes-related foot wounds treated by a multidisciplinary team. (#281)
1:30 PM
Is simulation training effective in increasing clinicians’ confidence in diabetic foot ulcer management? The Foot Ulcer Simulation Training Project (#282)
1:30 PM
New-Onset Diabetes Following Liver Transplant: Diabetes Treatment and Long Term Diabetic Complications (#283)
1:30 PM
Relationship between serum aldosterone levels and urinary sodium excretion in patients with diabetes in the presence and absence of renin angiotensin aldosterone blockade (#284)
1:30 PM
In patients attending the diabetes antenatal clinic, glucose capillary-venous difference is not affected by prandial status (#285)
1:30 PM
Diabetic Foot Osteomyelitis (DFO) from a High Risk Foot Clinic in Saudi Arabia. A Descriptive Study (#286)
1:30 PM
The impact of professional roles and organisation of care on the interactional determinants of collaboration for health professionals involved in the initiation of insulin (#287)
1:30 PM
Impact of Body Composition on the Accurate Assessment of Kidney Function in Indigenous Australians: the eGFR Study (#288)
1:30 PM
Identifying risk factors for hypoglycaemic episodes in hospital inpatients. (#289)
1:30 PM
Brittle Glycaemic Control in Type 1 Diabetes – A Management Dilemma (#290)
1:30 PM
Simple population health management can result in a 27% increase in the number of people with optimal control of their Diabetes in Australia (#291)
1:30 PM
Why are patients with FBGL > 7 mmol and RBGL >/==11.1 mmol remaining undiagnosed based on pathology data in 2011 and what can be done to increase awareness? (#292)
1:30 PM
The Effect of Insulin Degludec on Glycemic Control and Nocturnal Hypoglycemia Compared with Insulin Glargine: A 1-year Randomized Trial in Insulin-naïve People with Type 2 Diabetes (#293)
1:30 PM
Impact Of Smoking On Impaired Insulin Secretion In A Japanese Population: The Saku Central Hospital Health Dock Center Study (#294)
1:30 PM
Saxagliptin (SAXA) effectively reduces HbA1c and is well tolerated when added to a combination of metformin (MET) and sulphonylurea (SU) (#295)
1:30 PM
Perioperative diabetes audit identifies inconsistent practice and suboptimal glycaemia (#296)
1:30 PM
Clinical competencies for clinicians working in diabetes related foot ulcer management: standardising care. (#297)
1:30 PM
Audit of glycaemic control and management in patients with diabetes in a cardiac unit (#298)
1:30 PM
Safety of dapagliflozin in clinical trials for T2DM (#299)
1:30 PM
Durability of dapagliflozin treatment response in patients with T2DM: 2-year results (#300)
1:30 PM
Patient Factors Predicting the Success or Failure of Sitagliptin Therapy in Type 2 Diabetes Mellitus (#301)
1:30 PM
Evaluation of a weight based, fixed-rate insulin regime in adults with diabetic ketoacidosis (#302)
1:30 PM
Comparison of vildagliptin with placebo in a 24-week study of 221 patients with type 2 diabetes and severe renal impairment (eGFR<30) (#303)
1:30 PM
Doubling of diabetes prevalence in hospital inpatients from 1996 - 2012 (#304)
1:30 PM
Effect Of Twice Daily Exenatide In Combination With Insulin In Patients With Type 2 Diabetes (#305)
1:30 PM
Audit of outcomes of midwife-led gestational diabetes clinic (#306)
1:30 PM
Nocturnal Dipping of Mean Arterial Blood (MAP) Pressure is Related to Sodium Intake in Type 2 Diabetes and Abolished by morning angiotensin II receptor blockade (ARB) (#307)
1:30 PM
Does the shortage of diabetes specialists in regional and rural Australia matter? Results from Diabetes MILES - Australia (#308)
1:30 PM
Safety & efficacy of biphasic insulin as part in people with type 2 diabetes (T2D) switched from a basal-bolus regimen: results from the A1chieve study (#309)
1:30 PM
Pre-existing diabetes in pregnancy: Comparison between type 1 and type 2 diabetes: (#310)
1:30 PM
Increased Maternal Age and Primiparity of Women with Gestational Diabetes: Implications for Treatment and Workload (#311)
1:30 PM
Severe hypertriglyceridaemia in type 2 diabetes mellitus (#312)
1:30 PM
Impact of soybean products intake on incidents of type 2 diabetes mellitus in a japanese population: the saku central hospital health dock center study (#313)
1:30 PM
Effect of using standardised Queensland statewide Diabetes ketoacidosis (DKA) management protocol – An audit of 71 DKA admissions at the Townsville hospital (#314)
1:30 PM
Hypoglycemia In Inpatients With Diabetes On Nasogastric Feeding (#315)
1:30 PM
Sustained improvement in NEFA suppression during IVGTT 3 years after islet- transplantation. (#318)
1:30 PM
Body mass index correlates with ischemic heart disease and albuminuria in long-standing type 2 diabetes (#319)
1:30 PM
Urine metabolomic profiling of experimental hyperglycaemia – towards an improved test for diabetic nephropathy (#320)
1:30 PM
Baseline determinants of Exenatide success or failure in Type 2 Diabetes (#321)
1:30 PM
High rates of Gestational Diabetes in women who take antipsychotic medication during pregnancy (#322)
1:30 PM
Diabetes after paediatric lung transplant (#323)
1:30 PM
Fairfield Diabetes Clinic Communication Study (#324)
1:30 PM
The use and acceptance of information technology in Australian diabetes care: implications for the future. (#325)
1:30 PM
Correlation of cyp2e1 expression elevation with extent of glycemic control in comparison to traditional clinical markers for diabetic nephropathy (#326)
1:30 PM
Progression of Gestational Diabetes to Type 2 Diabetes amongst mothers from Cairns region in North Queensland who delivered in 2004 (1671)
1:30 PM